Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...
Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...
For Floridians who once considered traveling to Latin America or overseas for stem cell therapy, there is now a domestic ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...
Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...
This week, Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about research underway to explore the use of stem cell therapy ...
Clinical Trials Arena on MSN
CellProthera sets the scene for Phase III stem cell therapy trial
The biotech will soon evaluate the safety and efficacy of its regenerative cardiovascular stem cells, coined ProtheraCytes, ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...
Thinning hair has always been a symptom of aging, but experts say men seem to be losing their hair earlier than previous generations. Modern lifestyles may quicken hair loss due to increased stress, ...
Gallant and MWI have partnered to give veterinary practices safe and reliable access to off-the-shelf stem cell therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results